Hemostemix Historical Financial Ratios
| HEM Stock | CAD 0.07 0.01 11.76% |
Hemostemix is recently reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 or Invested Capital of 0.0 will help investors to properly organize and evaluate Hemostemix financial condition quickly.
Hemostemix |
About Hemostemix Financial Ratios Analysis
HemostemixFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Hemostemix investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Hemostemix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Hemostemix history.
Hemostemix Financial Ratios Chart
Add Fundamental
Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Hemostemix's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Hemostemix current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemostemix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Hemostemix's ROIC is fairly stable compared to the past year. Days Payables Outstanding is likely to climb to about 4.9 M in 2024, despite the fact that Book Value Per Share is likely to grow to (0.08).
Hemostemix fundamentals Correlations
Click cells to compare fundamentals
Hemostemix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hemostemix fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 48.98 | (0.74) | (20.54) | (1.74) | (1.86) | (0.78) | |
| Book Value Per Share | (0.27) | (0.0341) | (0.092) | (0.0967) | (0.0893) | (0.0849) | |
| Free Cash Flow Yield | (0.11) | (1.13) | (0.26) | (0.38) | (0.48) | (0.25) | |
| Operating Cash Flow Per Share | (0.23) | (0.19) | (0.0605) | (0.0872) | (0.0172) | (0.0181) | |
| Pb Ratio | 48.98 | (0.74) | (20.54) | (1.74) | (1.86) | (0.78) | |
| Free Cash Flow Per Share | (0.23) | (0.19) | (0.0605) | (0.0872) | (0.0172) | (0.0181) | |
| Roic | 2.42 | 8.2 | 1.68 | 1.91 | 0.77 | 0.8 | |
| Net Income Per Share | (0.32) | (0.24) | (0.11) | (0.0748) | (0.0303) | (0.0318) | |
| Cash Per Share | 0.001599 | 0.008001 | 0.00382 | 0.00194 | 0.001884 | 0.00179 | |
| Pocfratio | (0.88) | (3.78) | (2.64) | (2.06) | (4.07) | (4.27) | |
| Pfcf Ratio | (0.88) | (3.78) | (2.64) | (2.06) | (4.07) | (4.27) | |
| Income Quality | 0.7 | 0.77 | 0.55 | 1.17 | 0.57 | 0.81 | |
| Roe | 1.2 | 7.07 | 1.19 | 0.77 | 0.34 | 0.36 | |
| Ev To Operating Cash Flow | (1.48) | (3.76) | (3.01) | (2.72) | (7.0) | (7.35) | |
| Pe Ratio | (0.62) | (2.91) | (1.46) | (2.41) | (2.31) | (2.42) | |
| Return On Tangible Assets | (46.7) | (3.34) | (11.16) | (11.25) | (7.97) | (8.37) | |
| Ev To Free Cash Flow | (1.48) | (3.76) | (3.01) | (2.72) | (7.0) | (7.35) | |
| Earnings Yield | (1.62) | (0.34) | (0.68) | (0.42) | (0.43) | (0.45) | |
| Net Debt To E B I T D A | (0.43) | 0.0111 | (0.2) | (0.91) | (2.14) | (2.03) | |
| Current Ratio | 0.0241 | 0.68 | 0.13 | 0.18 | 0.11 | 0.1 | |
| Tangible Book Value Per Share | (0.27) | (0.0341) | (0.092) | (0.0967) | (0.0893) | (0.0849) | |
| Graham Number | 1.4 | 0.43 | 0.48 | 0.4 | 0.25 | 0.23 | |
| Shareholders Equity Per Share | (0.27) | (0.0341) | (0.092) | (0.0967) | (0.0893) | (0.0849) | |
| Graham Net Net | (0.27) | (0.0519) | (0.0935) | (0.0999) | (0.091) | (0.0865) | |
| Enterprise Value Over E B I T D A | (1.06) | (3.01) | (1.62) | (3.77) | (5.11) | (4.85) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.